September 30, 2025

The Unseen Journey Expands with Debut of MPN VisualAIzer

Symptoms of myeloproliferative neoplasms (MPNs), a group of rare, chronic and progressive blood cancers, are often misunderstood, difficult to track and challenging to assess. Common symptoms such as fatigue, brain fog and night sweats can easily be misinterpreted as signs of stress or aging when they could be a sign of disease progression.

To support people living with MPNs, Incyte launched The Unseen Journey, a program that illuminates the impact of MPN symptoms on patients’ lives. Using generative artificial intelligence (AI), the words and experiences of patients were transformed into powerful imagery illustrating both the physical and emotional toll of MPN symptoms, many of which are often invisible to others.

Now, Incyte is expanding the program with the MPN VisualAIzer, an interactive tool that turns written descriptions of MPN symptoms into vivid, 360-degree images in near real time.

This web-based tool offers patients the opportunity to create images themselves, allowing them to share their unique imagery and communicate their MPN experiences with family, friends and their care team in a way that words alone often can’t. It helps make the unseen seen by offering patients a creative way to express and share their symptom experiences.

In tandem with the tool launch, Incyte hosted an MPN Creator Lab event, bringing together patients and health care professionals in the MPN community to try it for themselves. Imagery created during the event demonstrated how it can spark more meaningful and open conversations about living with MPNs and managing symptoms.

Incyte is committed to helping patients be heard, understood and supported, and the MPN VisualAIzer was created to bridge the gap between what MPN symptoms feel like and how they’re understood.

Explore the MPN VisualAIzer and see some of the ways that people living with MPNs view their symptoms at the TheUnseenJourney.com.

The Unseen Journey
Serving Patients Through Innovation